The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Abstract
FBW7 (F-box and WD repeat domain-containing 7) is the substrate recognition component of an evolutionary conserved SCF (complex of SKP1, CUL1 and F-box protein)-type ubiquitin ligase. SCF(FBW7) degrades several proto-oncogenes that function in cellular growth and division pathways, including MYC, cyclin E, Notch and JUN. FBW7 is also a tumour suppressor, the regulatory network of which is perturbed in many human malignancies. Numerous cancer-associated mutations in FBW7 and its substrates have been identified, and loss of FBW7 function causes chromosomal instability and tumorigenesis. This Review focuses on structural and functional aspects of FBW7 and its role in the development of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FBXW7 ubiquitin ligase is a component of the SCF complex and mediates degradation of several cell cycle proteins,158 and its β-isoform is induced by p53.159”
From Census and evaluation of p53 target genes (2017) · cites this paper as [158]
Citations
Cites
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“Many mitogens induce JUN activity, and JUN functions as part of the AP1 transcription factor to exert its positive effect on cell proliferatio”
BackgroundActivating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,706
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,489
Genetic Control of the Cell Division Cycle in Yeast
Hartwell, L. H., Culotti, J. G., Pringle, J. R., & Reid, B. J. (1974) · Science · doi:10.1126/science.183.4120.46 · Cited by 1,567
Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex
Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., et al. (2002) · Nature · doi:10.1038/416703a · Cited by 1,507
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,493
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1881 · Cited by 1,450
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M. G., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,421
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J., & Harper, J. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80403-1 · Cited by 1,233
Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle
Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S. J., Nishimoto, T., Morgan, D. O., Franza, B. R., & Roberts, J. M. (1992) · Science · doi:10.1126/science.1388288 · Cited by 1,043
Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 942
Self-citationThe B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae
Schwob, É. (1994) · Cell · doi:10.1016/0092-8674(94)90193-7 · Cited by 886
Association of human cyclin E with a periodic G1-S phase protein kinase
Dulić, V., Lees, E. M., & Reed, S. I. (1992) · Science · doi:10.1126/science.1329201 · Cited by 884
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphomaPreprint
Weng, A. P., Millholland, J. M., Yashiro–Ohtani, Y., Arcangeli, M.-L., Lau, A. N., Wai, C., Bianco, C. D., Rodríguez, C. G., Sai, H., Tobias, J. W., et al. (2006) · Genes & Development · doi:10.1101/gad.1450406 · Cited by 863
Palomero, T., Lim, W. K., Odom, D. T., Sulis, M. L., Real, P. J., Margolin, A. A., Barnes, K., O’Neil, J., Neuberg, D. S., Weng, A. P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606108103 · Cited by 821
Feldman, R. M. R., Correll, C. C., Kaplan, K. B., & Deshaies, R. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80404-3 · Cited by 820
Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7
Yada, M., Hatakeyama, S., Kamura, T., Nishiyama, M., Tsunematsu, R., Imaki, H., Ishida, N., Okumura, F., Nakayama, K., & Nakayama, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600217 · Cited by 810
Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1110 · Cited by 791
Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCF Fbw7 Ubiquitin Ligase
Koepp, D. M., Schaefer, L. K., Ye, X., Keyomarsi, K., Chu, C., Harper, J. W., & Elledge, S. J. (2001) · Science · doi:10.1126/science.1065203 · Cited by 764
Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication
Nash, P., Tang, X., Orlicky, S. M., Chen, Q., Gertler, F. B., Mendenhall, M. D., Sicheri, F., Pawson, T. J., & Tyers, M. (2001) · Nature · doi:10.1038/35107009 · Cited by 761
GENETIC CONTROL OF THE CELL DIVISION CYCLE IN YEAST: V. GENETIC ANALYSIS OF cdc MUTANTS
Hartwell, L. H., Mortimer, R., Culotti, J. G., & Culotti, M. (1973) · Genetics · doi:10.1093/genetics/74.2.267 · Cited by 740
Systematic analysis and nomenclature of mammalian F-box proteinsPreprint
Jin, J., Cardozo, T. J., Lovering, R. C., Elledge, S. J., Pagano, M., & Harper, J. W. (2004) · Genes & Development · doi:10.1101/gad.1255304 · Cited by 718
Deregulated cyclin E induces chromosome instability
Spruck, C., Won, K., & Reed, S. I. (1999) · Nature · doi:10.1038/45836 · Cited by 692
O’Neil, J., Grim, J. A., Strack, P. R., Rao, S. S., Tibbitts, D., Winter, C. G., Hardwick, J. S., Welcker, M., Meijerink, J. P. P., Pieters, R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070876 · Cited by 681
Self-citationSustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC
Jain, M., Arvanitis, C., Chu, K., Dewey, W. C., Leonhardt, E. A., Trinh, M., Sundberg, C. D., Bishop, J. M., & Felsher, D. W. (2002) · Science · doi:10.1126/science.1071489 · Cited by 661
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
Grandori, C., Gomez-Roman, N., Felton-Edkins, Z. A., Ngouenet, C., Galloway, D. A., Eisenman, R. N., & White, R. J. (2005) · Nature Cell Biology · doi:10.1038/ncb1224 · Cited by 659
Insights into SCF ubiquitin ligases from the structure of the Skp1–Skp2 complex
Schulman, B. A., Carrano, A. C., Jeffrey, P. D., Bowen, Z., Kinnucan, E., Finnin, M. S., Elledge, S. J., Harper, J. W., Pagano, M., & Pavletich, N. P. (2000) · Nature · doi:10.1038/35042620 · Cited by 610
Strohmaier, H. M., Spruck, C., Kaiser, P., Won, K., Sangfelt, O., & Reed, S. I. (2001) · Nature · doi:10.1038/35095076 · Cited by 584
Inactivation of hCDC4 can cause chromosomal instability
Rajagopalan, H., Jallepalli, P. V., Rago, C., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Christoph Lengauer, C. (2004) · Nature · doi:10.1038/nature02313 · Cited by 552
Cyclin E in normal and neoplastic cell cycles
Hwang, H. C., & Clurman, B. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208613 · Cited by 522
Self-citationOrlicky, S. M., Tang, X., Willems, A. R., Tyers, M., & Sicheri, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00034-5 · Cited by 515
FBXW7/hCDC4 Is a General Tumor Suppressor in Human Cancer
Akhoondi, S., Sun, D., von der Lehr, N., Apostolidou, S., Klotz, K., Malyukova, A., Cepeda, D., Fiegl, H., Dafou, D., Marth, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1320 · Cited by 514
Clurman, B. E., Sheaff, R. J., Thress, K. S., Groudine, M. T., & Roberts, J. M. (1996) · Genes & Development · doi:10.1101/gad.10.16.1979 · Cited by 488
Self-citationThe SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia
Thompson, B. J., Buonamici, S., Sulis, M. L., Palomero, T., Vilimas, T., Basso, G., Ferrando, A. A., & Aifantis, I. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070872 · Cited by 488
The ubiquitin-specific protease USP28 is required for MYC stability
Popov, N., Wanzel, M., Madiredjo, M., Zhang, D., Beijersbergen, R. L., Bernards, R., Moll, R., Elledge, S. J., & Eilers, M. (2007) · Nature Cell Biology · doi:10.1038/ncb1601 · Cited by 484
A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin
Willems, A. R., Schwab, M. G., & Tyers, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.027 · Cited by 476
Hao, B., Oehlmann, S., Sowa, M. E., Harper, J. W., & Pavletich, N. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.022 · Cited by 469
Gregory, M. A., & Hann, S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469
Reduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases
Musti, A. M., Treier, M., & Bohmann, D. (1997) · Science · doi:10.1126/science.275.5298.400 · Cited by 463
Sundqvist, A., Bengoechea-Alonso, M. T., Ye, X., Lukiyanchuk, V., Jin, J., Harper, J. W., & Ericsson, J. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.04.010 · Cited by 457
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Hemann, M. T., Bric, A., Teruya‐Feldstein, J., Herbst, A., Nilsson, J. A., Cordon‐Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452
Phosphorylation of Sic1p by G 1 Cdk Required for Its Degradation and Entry into S Phase
Verma, R., Annan, R. S., Huddleston, M. J., Carr, S. A., Reynard, G. J., & Deshaies, R. J. (1997) · Science · doi:10.1126/science.278.5337.455 · Cited by 449
Avian sarcoma virus 17 carries the jun oncogene.
Maki, Y., Bos, T. J., Davis, C., Starbuck, M. W., & Vogt, P. K. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2848 · Cited by 440
Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines
Moberg, K. H., Bell, D. W., Wahrer, D. C. R., Haber, D. A., & Hariharan, I. K. (2001) · Nature · doi:10.1038/35095068 · Cited by 438
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia
Grabher, C., von Boehmer, H., & Look, A. T. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1880 · Cited by 427
Öberg, C., Li, J., Pauley, A. M., Wolf, E., Gurney, M. E., & Lendahl, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103992200 · Cited by 412
Wei, W., Jin, J., Schlisio, S., Harper, J. W., & Kaelin, W. G. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.005 · Cited by 403
DNA Copy Number Losses in Human Neoplasms
Knuutila, S., Aalto, Y., Autio, K., Björkqvist, A., El-Rifai, W. M., Hemmer, S., Huhta, T., Kettunen, E., Kiuru‐Kuhlefelt, S., Larramendy, M. L., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65166-8 · Cited by 391
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene
Mao, J.-H., Perez-losada, J., Wu, D., DelRosario, R., Tsunematsu, R., Nakayama, K. I., Brown, K., Bryson, S., & Balmain, A. (2004) · Nature · doi:10.1038/nature03155 · Cited by 390
Gupta-Rossi, N., Bail, O. L., Gonen, H., Brou, C., Logeat, F., Six, E. M., Ciechanover, A. J., & Israël, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101343200 · Cited by 379
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Maser, R. S., Choudhury, B., Campbell, P. J., Feng, B., Wong, K.-K., Protopopov, A., O’Neil, J., Gutierrez, A., Ivanova, E., Perna, I., et al. (2007) · Nature · doi:10.1038/nature05886 · Cited by 377
Multisite Phosphorylation by Cdk2 and GSK3 Controls Cyclin E Degradation
Welcker, M., Singer, J. D., Loeb, K. R., Grim, J. A., Bloecher, A., Gurian-West, M., Clurman, B. E., & Roberts, J. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00287-9 · Cited by 369
Self-citationWon, K. A., & Reed, S. I. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00793.x · Cited by 362
Wu, G., Lyapina, S., Das, I., Li, J., Gurney, M. E., Pauley, A. M., Chui, I., Deshaies, R. J., & Kitajewski, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7403-7415.2001 · Cited by 345
The Ubiquitin Ligase SCF Fbw7 Antagonizes Apoptotic JNK Signaling
Nateri, A. S., Riera-Sans, L., Costa, C. D., & Behrens, A. (2004) · Science · doi:10.1126/science.1092880 · Cited by 339
Ubiquitin: Roles in protein modification and breakdown
Hershko, A. (1983) · Cell · doi:10.1016/0092-8674(83)90131-9 · Cited by 313
A Nucleolar Isoform of the Fbw7 Ubiquitin Ligase Regulates c-Myc and Cell Size
Welcker, M., Orian, A., Grim, J. A., Eisenman, R. N., & Clurman, B. E. (2004) · Current Biology · doi:10.1016/j.cub.2004.09.083 · Cited by 311
Self-citationThe Cdc4/34/53 pathway targets Cdc6p for proteolysis in budding yeast
Drury, L. S., Perkins, G. R., & Diffley, J. F. X. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5966 · Cited by 287
SREBP in signal transduction: cholesterol metabolism and beyond
Bengoechea-Alonso, M. T., & Ericsson, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.004 · Cited by 284
Bahram, F., von der Lehr, N., Cetinkaya, C., & Larsson, L. (2000) · Blood · doi:10.1182/blood.v95.6.2104 · Cited by 283
Mouse Fbw7/Sel-10/Cdc4 Is Required for Notch Degradation during Vascular Development
Tsunematsu, R., Nakayama, K., Oike, Y., Nishiyama, M., Ishida, N., Hatakeyama, S., Bessho, Y., Kageyama, R., Suda, T., & Nakayama, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312337200 · Cited by 277
hCDC4 gene mutations in endometrial cancer.
Spruck, C., Strohmaier, H. M., Sangfelt, O., Müller, H. M., Hubalek, M., Müller‐Holzner, E., Marth, C., Widschwendter, M., & Reed, S. I. (2002) · PubMed · Cited by 268
Notch1 Contributes to Mouse T-Cell Leukemia by Directly Inducing the Expression of c-myc
Sharma, V. M., Calvo, J. A., Draheim, K., Cunningham, L. A., Hermance, N. M., Beverly, L. J., Krishnamoorthy, V., Bhasin, M., Capobianco, A. J., & Kelliher, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01091-06 · Cited by 265
Tetzlaff, M. T., Yu, W., Li, M. Z., Zhang, P., Finegold, M. J., Mahon, K., Harper, J. W., Schwartz, R. J., & Elledge, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307875101 · Cited by 253
Induction of Mammary Gland Hyperplasia and Carcinomas in Transgenic Mice Expressing Human Cyclin E
Bortner, D. M., & Rosenberg, M. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.453 · Cited by 245
Hubbard, E. J. A., Wu, G., Kitajewski, J., & Greenwald, I. (1997) · Genes & Development · doi:10.1101/gad.11.23.3182 · Cited by 232
BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) Mutations in Distinct Subsets of Pancreatic Cancer
Calhoun, E. S., Jones, J., Ashfaq, R., Adsay, V. N., Baker, S. J., Valentine, V. A., Hempen, P. M., Hilgers, W., Yeo, C. J., Hruban, R. H., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63485-2 · Cited by 231
Tang, X., Orlicky, S., Lin, Z., Willems, A., Neculai, D., Ceccarelli, D., Mercurio, F., Shilton, B. H., Sicheri, F., & Tyers, M. (2007) · Cell · doi:10.1016/j.cell.2007.04.042 · Cited by 209
Klinakis, A., Szabolcs, M. J., Politi, K. A., Kiaris, H., Artavanis‐Tsakonas, S., & Efstratiadis, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603371103 · Cited by 208
Henchoz, S., Chi, Y., Catarin, B., Herskowitz, I., Deshaies, R. J., & Peter, M. (1997) · Genes & Development · doi:10.1101/gad.11.22.3046 · Cited by 205
Malyukova, A., Dohda, T., von der Lehr, N., Akhoondi, S., Corcoran, M., Heyman, M. M., Spruck, C., Grandér, D., Lendahl, U., & Sangfelt, O. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4381 · Cited by 199
Kinase-independent function of cyclin E
Geng, Y., Lee, Y.-M., Welcker, M., Swanger, J., Zagozdzon, A., Winer, J. D., Roberts, J. M., Kaldis, P., Clurman, B. E., & Sicinski, P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.029 · Cited by 187
Self-citationOnoyama, I., Tsunematsu, R., Matsumoto, A., Kimura, T., de Alborán, I. M., Nakayama, K., & Nakayama, K. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062299 · Cited by 186
SIC1 is ubiquitinated in vitro by a pathway that requires CDC4, CDC34, and cyclin/CDK activities.
Verma, R., Feldman, R. M. R., & Deshaies, R. J. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.8.1427 · Cited by 172
Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide
Issaeva, N., Friedler, A., Bozko, P. M., Wiman, K. G., Fersht, A. R., & Selivanova, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835733100 · Cited by 144
c-Jun NH2-terminal Kinases Target the Ubiquitination of Their Associated Transcription Factors
Fuchs, S. Y., Xie, B., Adler, V., Fried, V. A., Davis, R. J., & Ronai, Z. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32163 · Cited by 140
Recognition of Phosphodegron Motifs in Human Cyclin E by the SCFFbw7 Ubiquitin Ligase
Ye, X., Nalepa, G., Welcker, M., Kessler, B. M., Spooner, E., Qin, J., Elledge, S. J., Clurman, B. E., & Harper, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409226200 · Cited by 138
Self-citationHomodimer of Two F-box Proteins βTrCP1 or βTrCP2 Binds to IκBα for Signal-dependent Ubiquitination
Suzuki, H., Chiba, T., Suzuki, T., Fujita, T., Ikenoue, T., Omata, M., Furuichi, K., Shikama, H., & Tanaka, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2877 · Cited by 131
Punga, T., Bengoechea-Alonso, M. T., & Ericsson, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604983200 · Cited by 129
hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53
Kimura, T., Gotoh, M., Nakamura, Y., & Arakawa, H. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01460.x · Cited by 127
Meimoun, A., Holtzman, T., Weissman, Z., McBride, H. J., Stillman, D. J., Fink, G. R., & Kornitzer, D. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.3.915 · Cited by 126
Sundaram, M. V., & Greenwald, I. (1993) · Genetics · doi:10.1093/genetics/135.3.765 · Cited by 124
p53 and p21 Form an Inducible Barrier that Protects Cells against Cyclin E-cdk2 Deregulation
Minella, A. C., Swanger, J., Bryant, E. M., Welcker, M., Hwang, H. C., & Clurman, B. E. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01225-3 · Cited by 119
Self-citationBenito, J., Martı́n-Castellanos, C., & Moreno, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.482 · Cited by 116
Fbw7/hCDC4 dimerization regulates its substrate interactions.
Welcker, M., & Clurman, B. E. (2007) · Cell Division · doi:10.1186/1747-1028-2-7 · Cited by 115
Self-citationvan Drogen, F., Sangfelt, O., Malyukova, A., Matskova, L. V., Yeh, E. S., Means, A. R., & Reed, S. I. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.020 · Cited by 112
A mouse model for cyclin E-dependent genetic instability and tumorigenesis
Loeb, K. R., Kostner, H., Firpo, E. J., Norwood, T. H., Tsuchiya, K. D., Clurman, B. E., & Roberts, J. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.010 · Cited by 109
Self-citationSeparate SCFCDC4 recognition elements target Cdc6 for proteolysis in S phase and mitosis
Perkins, G. R., Drury, L. S., & Diffley, J. F. X. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4836 · Cited by 108
Kominami, K., Ochotorena, I., & Toda, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00225.x · Cited by 104
The Loss of PIN1 Deregulates Cyclin E and Sensitizes Mouse Embryo Fibroblasts to Genomic Instability
Yeh, E. S., Lew, B. O., & Means, A. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505770200 · Cited by 98
Activation by c-Myc of transcription by RNA polymerases I, II and III
Gomez-Roman, N., Felton-Edkins, Z. A., Kenneth, N. S., Goodfellow, S. J., Athineos, D., Zhang, J., Ramsbottom, B. A., Innes, F., Kantidakis, T., Kerr, E. R., et al. (2006) · Biochemical Society Symposia · doi:10.1042/bss0730141 · Cited by 95
Mutation of hCDC4 Leads to Cell Cycle Deregulation of Cyclin E in Cancer
Reed, S. E., Spruck, C., Sangfelt, O., van Drogen, F., Mueller‐Holzner, E., Widschwendter, M., Zetterberg, A., & Reed, S. I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3417 · Cited by 95
Kemp, Z., Rowan, A., Chambers, W. M., Wortham, N. C., Halford, S. E. R., Sieber, O. M., Mortensen, N., Herbay, A. V., Gunther, T., Ilyas, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2565 · Cited by 90
Myc degradation: Dancing with ubiquitin ligases
Amati, B. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403046101 · Cited by 79
Hagedorn, M., Delugin, M., Abraldes, I., Allain, N., Belaud‐Rotureau, M., Turmo, M., Prigent, C., Loiseau, H., Bikfalvi, A., & Javerzat, S. (2007) · Cell Division · doi:10.1186/1747-1028-2-9 · Cited by 75
Welcker, M., & Clurman, B. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413377200 · Cited by 73
Self-citationLi, J., Pauley, A. M., Myers, R. L., Shuang, R., Brashler, J. R., Yan, R., Buhl, A. E., Ruble, C., & Gurney, M. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01105.x · Cited by 72
Fbw7 Isoform Interaction Contributes to Cyclin E Proteolysis
Zhang, W., & Koepp, D. M. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0253 · Cited by 67
Wu, G., Hubbard, E. J. A., Kitajewski, J., & Greenwald, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15787 · Cited by 62
Kishi, T., Ikeda, A., Nagao, R., & Koyama, N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704951104 · Cited by 61
p53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability
Minella, A. C., Grim, J., Welcker, M., & Clurman, B. E. (2007) · Oncogene · doi:10.1038/sj.onc.1210518 · Cited by 61
Self-citationRas activity regulates cyclin E degradation by the Fbw7 pathway
Minella, A. C., Welcker, M., & Clurman, B. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503677102 · Cited by 61
Self-citationExpression of mouse Fbxw7 isoforms is regulated in a cell cycle- or p53-dependent manner
Matsumoto, A., Onoyama, I., & Nakayama, K. I. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.003 · Cited by 58
Cyclin E dysregulation and chromosomal instability in endometrial cancer
Hubalek, M., Widschwendter, A., Erdel, M., Gschwendtner, A., Fiegl, H., Müller, H. M., Goebel, G., Mueller‐Holzner, E., Marth, C., Spruck, C., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207560 · Cited by 56
Radtke, F., Schweisguth, F., & Pear, W. S. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400585 · Cited by 56
Sequence curiosity in v-myc oncogene
Papas, T. S., & Lautenberger, J. A. (1985) · Nature · doi:10.1038/318237a0 · Cited by 54
Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer
Kwak, E. L., Moberg, K. H., Wahrer, D. C. R., Quinn, J. E., Gilmore, P. M., Graham, C. A., Hariharan, I. K., Harkin, D. P., Haber, D. A., & Bell, D. W. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.04.007 · Cited by 52
Mutational analysis of the hCDC4 gene in gastric carcinomas
Lee, J. W., Soung, Y. H., Kim, H. J., Park, W. S., Nam, S. W., Kim, S., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.10.034 · Cited by 41
Smith, A. P. L., Henze, M., Lee, J. A., Osborn, K. G., Keck, J. M., Tedesco, D., Bortner, D. M., Rosenberg, M. P., & Reed, S. I. (2006) · Oncogene · doi:10.1038/sj.onc.1209713 · Cited by 32
The FBXW7 β-form is suppressed in human glioma cells
Gu, Z., Inomata, K., Ishizawa, K., & Horii, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.080 · Cited by 28
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer
Koh, M. S., Ittmann, M., Kadmon, D., Thompson, T. C., & Leach, F. S. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.1.2290 · Cited by 26
Characterization of a Mouse Gene (Fbxw6) That Encodes a Homologue of Caenorhabditis elegans SEL-10
Maruyama, S.-I., Hatakeyama, S., Nakayama, K., Ishida, N., Kawakami, K., & Nakayama, K. (2001) · Genomics · doi:10.1006/geno.2001.6658 · Cited by 25
Mutation Analysis of hCDC4 in AML Cells Identifies a New Intronic Polymorphism
Nowak, D., Mossner, M., Baldus, C. D., Hopfer, O., Thiel, E., & Hofmann, W. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.148 · Cited by 15
Somatic mutation ofhCDC4gene is rare in lung adenocarcinomas
Lee, J. W., Soung, Y. H., Kim, S. Y., Nam, S. W., Park, W. S., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2005) · Acta Oncologica · doi:10.1080/02841860500400979 · Cited by 13
hCDC4 variation in osteosarcoma
Yan, T., Wunder, J. S., Gökgöz, N., Seto, K., Bell, R. S., & Andrulis, I. L. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.04.007 · Cited by 12
Low frequency of hCDC4 mutations in human primary ovarian cancer
Sgambato, A., Masciullo, V., Salvatore, M. D., Valdivieso, P., Bianchino, G., Zupa, A., Improta, G., Graziani, C., Rettino, A., Cifarelli, R. A., et al. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.01.026 · Cited by 8
Ubiquitin Ligase Component Fbw7 Regulates the Quiescence of Hematopoietic Stem Cells.
Matsuoka, S., Oike, Y., Onoyama, I., Takubo, K., Ito, K., Arai, F., Ikeda, Y., Nakayama, K., Nakayama, K., & Suda, T. (2006) · Blood · doi:10.1182/blood.v108.11.79.79 · Cited by 1
Flagged first, then by citations
Cited by
Sorted by citations
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Global signatures of protein and mRNA expression levels
de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M., & Vogel, C. (2009) · Molecular BioSystems · doi:10.1039/b908315d · Cited by 1,248
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,144
Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
Yang, Y., Gao, X., Zhang, M., Yan, S., Sun, C., Xiao, F., Huang, N., Yang, X., Zhao, K., Zhou, H., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx166 · Cited by 1,114
Metadata
- Authors
- Welcker, M., & Clurman, B. E.
- Affiliations
- Fred Hutch Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Welcker, Markus
- Venue
- Nature Reviews Cancer
- Published
- 2008-02
- Volume
- 8
- Issue
- 2
- Pages
- 83-93
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2142183096
- Cited by
- 1,084
- References
- 120
- Citations by year
- 2026: 33 · 2025: 34 · 2024: 34 · 2023: 38 · 2022: 53 · 2021: 67 · 2020: 64 · 2019: 69 · 2018: 67 · 2017: 68 · 2016: 74 · 2015: 77 · 2014: 73 · 2013: 82 · 2012: 76
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL084205)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- FBXW7, SCF ubiquitin ligase, tumour suppressor, MYC degradation, cyclin E, notches, c-Jun, chromosomal instability, carcinogenesis, cancer-associated mutations, cell division, cell growth, cell differentiation
- MeSH terms
- F-Box-WD Repeat-Containing Protein 7, Animals, Cell Differentiation, Cell Division, Humans, Models, Biological, Mutation, Neoplasms, Gene Expression Regulation, Neoplastic, Cell Cycle Proteins, Dimerization, Cyclin E, Ubiquitin-Protein Ligases, F-Box Proteins, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review